Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 3Breast Neoplasms 2Turcot syndrome 1Stomach Neoplasms 1Stereotactic Body Radiation Therapy 1Rectal Neoplasms 1Pancreatic Neuroendocrine Tumors (pNET) 1Neoplasm, Residual 1NSCLC 1Microsatellite Instability 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bites and Stings 1

Interventions

blinatumomab 2venetoclax 1osimertinib 1Vincristine 1Transplantation 1Sorafenib 1Radiotherapy 1Oxaliplatin 1Neoadjuvant Therapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methotrexate 1Maintenance 1Liquid Biopsy 1Leucovorin 1Irinotecan 1Hematologic Tests 1Fluorouracil 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Blood Specimen Collection 1BEBT-908 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasm, Residual × Chemotherapy, Adjuvant × Clear all
NCT07413146 2026-02-17

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Sun Yat-sen University

Phase NA Not yet recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡